No influence of SLC6A3 40 base VNTR polymorphism on the response to risperidone

References

• Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, . Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992;14(4):1104–6.
   Google Scholar
• Gelernter J, Kranzler H, Lacobelle J. Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF)). Genomics 1998;52(3):289–97.
   Google Scholar
• Gizer IR, Ficks C, Waldman ID. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet 2009;126(1):51–90.
   PubMedGoogle Scholar
• Gelernter J, Kranzler HR, Satel SL, Rao PA. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology 1994;11(3):195–200.
   Google Scholar
• Sander T, Harms H, Dufeu P, Kuhn S, Rommelspacher H, Schmidt LG. Dopamine D4 receptor exon III alleles and variation of novelty seeking in alcoholics. Am J Med Genet 1997;74(5):483–7.
   Google Scholar
• Schmidt LG, Harms H, Kuhn S, Rommelspacher H, Sander T. Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene. Am J Psychiatry 1998;155(4):474–8.
   Google Scholar
• Lerman C, Caporaso NE, Audrain J, Main D, Bowman ED, Lockshin B, . Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol 1999;18(1):14–20.
   Google Scholar
• Sabol SZ, Nelson ML, Fisher C, Gunzerath L, Brody CL, Hu S, . A genetic association for cigarette smoking behavior. Health Psychol 1999;18(1):7–13.
   Google Scholar
• Liu HC, Lin SK, Liu SK, Chen SL, Hu CJ, Chang JG, . DAT polymorphism and diverse clinical manifestations in methamphetamine abusers. Psychiatr Genet 2004;14(1):33–7.
   Google Scholar
• Persico AM, Vandenbergh DJ, Smith SS, Uhl GR. Dopamine transporter gene polymorphisms are not associated with polysubstance abuse. Biol Psychiatry 1993;34(4):265–7.
   Google Scholar
• Persico AM, Catalano M. Lack of association between dopamine transporter gene polymorphisms and delusional disorder. Am J Med Genet 1998;81(2):163–5.
   Google Scholar
• Gelernter J, Rao PA, Pauls DL, Hamblin MW, Sibley DR, Kidd KK. Assignment of the 5HT7 receptor gene (HTR7) to chromosome 10q and exclusion of genetic linkage with Tourette syndrome. Genomics 1995;26(2):207–9.
   Google Scholar
• Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A, . Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol Psychiatry 1997;41(3):299–304.
   Google Scholar
• Gamma F, Faraone SV, Glatt SJ, Yeh YC, Tsuang MT. Meta-analysis shows schizophrenia is not associated with the 40-base-pair repeat polymorphism of the dopamine transporter gene. Schizophr Res 2005;73(1):55–8.
   Google Scholar
• Guzey C, Scordo MG, Spina E, Landsem VM, Spigset O. Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms. Eur J Clin Pharmacol 2007;63(3):233–41.
   Google Scholar
• Lafuente A, Bernardo M, Mas S, Crescenti A, Aparici M, Gasso P, . Dopamine transporter (DAT) genotype (VNTR) and phenotype in extrapyramidal symptoms induced by antipsychotics. Schizophr Res 2007;90(1–3):115–22.
   Google Scholar
• Rybakowski JK, Borkowska A, Czerski PM, Dmitrzak-Weglarz M, Skibinska M, Kapelski P, . Performance on the Wisconsin Card Sorting Test in schizophrenia and genes of dopaminergic inactivation (COMT, DAT, NET). Psychiatry Res 2006;143(1):13–9.
   Google Scholar
• Martinez D, Gelernter J, Abi-Dargham A, van Dyck CH, Kegeles L, Innis RB, . The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology 2001;24(5):553–60.
   Google Scholar
• Szekeres G, Keri S, Juhasz A, Rimanoczy A, Szendi I, Czimmer C, . Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2004;124B(1):1–5.
   PubMed Web of Science ®Google Scholar
• Zhang A, Xing Q, Wang L, Du J, Yu L, Lin Z, . Dopamine transporter polymorphisms and risperidone response in Chinese schizophrenia patients: an association study. Pharmacogenomics 2007;8(10):1337–45.
   Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, . The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl 20):22–33;quiz 4–57.
   PubMed Web of Science ®Google Scholar
• Guy W. Clinical Global Impression. In: Assesment manual for psychopharmacology. Washington, DC: Department of Health Education and Welfare; 1976. 217–22.
   Google Scholar
• Flemenbaum A, Zimmermann RL. Inter- and intra-rater reliability of the Brief Psychiatric Rating Scale. Psychol Rep 1973;32(3):783–92.
   PubMedGoogle Scholar
• Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13(2):261–76.
   PubMed Web of Science ®Google Scholar
• StatSoft. STATISTICA per Windows. http://www.statsoft.com/textbook/Stathome.html. 2009.
   Google Scholar
• Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21(2):263–5.
   PubMed Web of Science ®Google Scholar
• Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
   Google Scholar
• Jeong SH, Joo EJ, Ahn YM, Kim YS. Association study of dopamine transporter gene and schizophrenia in Korean population using multiple single nucleotide polymorphism markers. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28(6):975–83.
   Google Scholar
• Kim JY, Jung IK, Han C, Cho SH, Kim L, Kim SH, . Antipsychotics and dopamine transporter gene polymorphisms in delirium patients. Psychiatry Clin Neurosci 2005;59(2):183–8.
   Google Scholar
• Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, . Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 2000;22(2):133–9.
   Google Scholar
• Jacobsen LK, Staley JK, Zoghbi SS, Seibyl JP, Kosten TR, Innis RB, . Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry 2000;157(10):1700–3.
   Google Scholar
• Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 2001;1(2):152–6.
   Google Scholar